| Identification | Back Directory | [Name]
4-(4-((2R,3R)-3-(3-carbaMiMidoylbenzyl)-4-Methoxy-4-oxobutan-2-ylcarbaMoyl)phenyl)pyridine 1-oxide (Hydrochloride) | [CAS]
409081-12-5 | [Synonyms]
Otamixaban HCl
4-(4-((2R,3R)-3-(3-carbaMiMidoylbenzyl)-4-Methoxy-4-oxobutan-2-ylcarbaMoyl)phenyl)pyridine 1-oxide (Hydrochloride) | [Molecular Formula]
C25H27ClN4O4 | [MOL File]
409081-12-5.mol | [Molecular Weight]
482.97 |
| Hazard Information | Back Directory | [Uses]
Otamixaban (FXV673) is a potent, selective, rapid-acting, competitive, and reversible fXa inhibitor (Ki=0.5 nM) that effectively inhibits both free and prothrombinase-bound fXa[1]. | [References]
[1] Eikelboom JW, Weitz JI.Otamixaban in acute coronary syndromes.Lancet. 2009 Sep 5;374(9692):762-4. Epub 2009 Aug 28. DOI:10.1016/S0140-6736(09)61529-4 |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|